Lars Ny

19PUBLICATIONS
64CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTe hauora mamao o te Māori (Māori remote health)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 07, 2025
Evaluation of the flipped dose NIVO3+IPI1 in patients with advanced unresectable melanoma.

Karl Björkström, Cissi Liu, Anna Fager

|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Vasu R Sah, Henrik Jespersen, Joakim Karlsson

|Jun 10, 2023
Targeted Therapy in the Palliative Setting of Colorectal Cancer-Survival and Medical Costs.

Kamuran Inci, Bengt Nilsson, Lars Ny

|Mar 20, 2023
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).

Roger Olofsson Bagge, Axel Nelson, Amir Shafazand

|Feb 11, 2023
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.

Elin M V Forsberg, Rebecca Riise, Sara Saellström

|Jan 08, 2023
Tumor Burden and Health-Related Quality of Life in Patients with Melanoma In-Transit Metastases.

Hanna Wesslau, Anders Carlander, Lars Ny

Pageof 4

Frequent Collaborators

10 joint publications

Roger Olofsson Bagge

6 joint publications

Jonas Nilsson

5 joint publications

Hildur Helgadottir

3 joint publications

Dimitrios Katsarelias